Prostatic NeoplasmsProstatic DiseasesDocetaxel
John P. Morcos
NPI1013052216PAC ID0244333441
- Medicare services, 2024
- 1,090
- Medicare patients, 2024
- 292
- Part D claims, 2024
- 1,130
- Clinical trials
- 1
- MIPS score, 2024
- 64
- Practice address
- 300 Halket Street, Pittsburgh, PA 15213
- Practice phone
- Call (412) 641-4010
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find John Morcos' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
John P. Morcos is a hematologist and oncologist in Pittsburgh, Pennsylvania
John Morcos practices at UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.
John Morcos' NPI, 1013052216, was assigned on February 21, 2007. John Morcos graduated from Duke University School of Medicine in 2001. John Morcos holds Pennsylvania license MD424962.
NPI and contact details
- NPI
- 1013052216NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0244333441
- NPI enumeration date
- February 21, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (412) 641-4010
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 51
- Medical school graduation
- 2001
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
John P. Morcos practices at UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania
John Morcos' primary practice is UPMC Magee-Womens Hospital, at 300 Halket Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 641-4010.
- UPMC Magee-Womens Hospital300 Halket Street, Pittsburgh, PA 15213 · Allegheny CountyPhone(412) 641-4010
Source: Dmand AI Affiliation Data
John P. Morcos is affiliated with 7 sites of care and 2 medical groups
John Morcos' primary practice is UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. John Morcos is also affiliated with UPMC Presbyterian. The medical group on file is UPMC Hillman Cancer Center. Dmand AI also links John Morcos to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.
UPMC PresbyterianUPMC Hillman Cancer Center3 hospitalsNames with a free account2 group practices and clinicsNames with a free account1 medical groupName with a free account
See all 9 affiliations for John MorcosSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at John P. Morcos' practice
Dmand AI tracks the electronic health record (EHR) system at each site where John Morcos practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| UPMC Magee-Womens Hospital | Available with a free account |
| +6 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where John Morcos practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Pittsburgh Medical Center and 6.2K+ hospitals, with verified contacts in the same login.
John P. Morcos is one of 645 hematologists and oncologists in Pennsylvania
Hematology and oncology is John Morcos' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. John Morcos is licensed in Pennsylvania.
Specialties and state licenses
- Hematology and oncology, PennsylvaniaPrimary
Hematologists and oncologists near John Morcos
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
645hematologists and oncologists in Pennsylvania110hematologists and oncologists in Pittsburgh42hematologists and oncologists at UPMC Magee-Womens Hospital
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
John P. Morcos billed Medicare for 1,090 services in 2024
CMS data shows 1,090 Medicare services from John Morcos across 8 procedure codes in 2024, for 292 Medicare patients. Medicare paid $71,512 for them.
Medicare services, 20241,090
Medicare patients292
Paid by Medicare$71,512
Procedure codes8
John Morcos' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 8362024: 93612%
- Other services
- 2023: 02024: 154
Where John Morcos' Medicare services took place, 2024
- In an office47944%
- In a facility61156%
John Morcos compared with the Pennsylvania median for hematologists and oncologists, 2024
- John Morcos
- Pennsylvania median
- Medicare services
- 1,090vs 65467% above
- Medicare patients
- 292vs 22729% above
- Part D claims
- 972vs 3932.5 times
Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.
John Morcos' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for John Morcos?
Medicare shows one payer. Book a meeting to get commercial claims data for John Morcos and other hematologists and oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
John P. Morcos treated 292 Medicare patients in 2024, average age 74
CMS counts 292 Medicare patients who saw John Morcos in 2024. The largest group is 65 to 74, with 151 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts John Morcos' median patient age at 73, with 55% women.
Medicare patients, 2024292
Average age74
Average risk score2.04
Also on Medicaid7%
John Morcos' Medicare patients by age, 2024
John Morcos' Medicare patients by sex, 2024
- Women14951%
- Men14349%
Chronic conditions among John Morcos' Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis49%
- Cancer40%
- Chronic kidney disease39%
- Ischemic heart disease36%
- Diabetes34%
- Anxiety29%
Share of Medicare patients with each condition. A patient can have several.
John Morcos' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women55%
- Men44%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
John P. Morcos wrote 1,130 Medicare Part D claims in 2024
In 2024, John Morcos wrote 1,130 Medicare Part D claims for 195 patients. 70% of them were for generic drugs. CMS names the drug for 972 of them, across 28 drugs with 11 or more claims each, at $2,169,804 in total drug cost. In 2023, CMS named 855 claims across 23 drugs.
Part D claims, 20241,130
Drugs named by CMS28
Total drug cost$2.2M
Part D patients195
John Morcos' Part D claims by kind of drug, 2024
- Generic787 claims70%
- Brand-name343 claims30%
John Morcos' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in John Morcos' Part D claims, 2024
- Opioids4%47 of 1,130 claims
- Antibiotics2%28 of 1,130 claims
- Antipsychotics, patients 65 and over2%17 of 1,130 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 8552024: 97214%
Drugs named by CMS: 28 in 2024, 23 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
John P. Morcos scored 64 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 64 out of 100 for John Morcos for performance year 2024, reported as part of a group. John Morcos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
John Morcos' MIPS scores, performance year 2024
- 64of 100Final score
- 38.2of 100Quality
- 40of 100Improvement Activities
- 84of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like John Morcos by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
John P. Morcos has worked on 1 clinical trial
Dmand AI links John Morcos to 1 clinical trial. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.
Conditions in John Morcos' trials
- Prostatic Neoplasms
- Prostatic Diseases
Investigators on the most trials with John Morcos
- Cindylou F. Connell, MD1 shared trial
- Theodore L. Crandall, MD1 shared trial
- Terry L. Evans, MD1 shared trial
Recent clinical trials with John Morcos
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
John P. Morcos received $10,424 in industry payments from 2016 to 2025
CMS Open Payments shows 64 general payments to John Morcos from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,608.
General payments to John Morcos by program year, 2016 to 2025
General payments to John Morcos by kind, 2016 to 2025
$10.4Kin total
- Consulting fees$6,19259%
- Food and beverage$3,17730%
- Honoraria$6006%
- Education$3974%
- Travel and lodging$581%
Companies that paid John Morcos the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
John P. Morcos graduated from Duke University School of Medicine
John Morcos graduated from Duke University School of Medicine in 2001.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for John P. Morcos's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about John P. Morcos
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is John P. Morcos' NPI number?
John P. Morcos' NPI number is 1013052216. It was assigned on February 21, 2007, and it is active in the NPI Registry.
What does John P. Morcos specialize in?
John P. Morcos is a hematologist and oncologist in Pittsburgh, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does John P. Morcos practice?
John Morcos practices at 300 Halket Street, Pittsburgh, PA 15213. John Morcos' primary practice is UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dmand AI also links John Morcos to 3 hospitals, 2 group practices and clinics and 1 medical group.
What is John P. Morcos' office phone number?
The practice phone on file for John Morcos is (412) 641-4010.
What is John P. Morcos' medical license number?
John Morcos holds Pennsylvania license MD424962.
Which hospitals is John P. Morcos affiliated with?
John Morcos practices at UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania. John Morcos is also affiliated with UPMC Presbyterian. Dmand AI links John Morcos to 3 more hospitals.
What medical group is John P. Morcos part of?
John Morcos is linked to UPMC Hillman Cancer Center. Dmand AI links John Morcos to 1 more medical group.
Does John P. Morcos accept Medicare?
Yes. CMS data shows John Morcos billed Medicare for 1,090 services in 2024, and John Morcos accepts Medicare assignment.
What is John P. Morcos' MIPS score?
John Morcos' MIPS final score for performance year 2024 is 64 out of 100, reported as part of a group.
How many Medicare patients does John P. Morcos see?
CMS counts 292 Medicare patients who saw John Morcos in 2024, with an average age of 74.
Show 6 more questionsShow fewer questions
What services does John P. Morcos bill to Medicare?
In 2024, John Morcos' most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and medicare service (G2211).
Where did John P. Morcos go to medical school?
John Morcos graduated from Duke University School of Medicine in 2001.
What drugs does John P. Morcos prescribe most?
In 2024 Medicare Part D data, John Morcos' most prescribed drugs by claims were Anastrozole, Eliquis and Hydroxyurea.
Has John P. Morcos received payments from drug or device companies?
CMS Open Payments shows $10,424 in general payments to John Morcos from 21 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has John P. Morcos been practicing?
John Morcos graduated from medical school in 2001, 25 years ago.
Does John P. Morcos do research?
John Morcos has worked on 1 clinical trial.
Selling to hematology and oncology practices?
See hematologists and oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card